Dr. Patrick A Cockerill , MD
Urology • Live Oak, TX
12709 Toepperwein Rd Ste 206
Live Oak, TX 782333260
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on June 17, 2011; this date does not establish years in practice.
-
Published CMS data list 13,227 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J0897 — Injection, denosumab, 1 mg: 2,340 service units.
- 87798 — Detection test by nucleic acid for organism, amplified probe technique: 2,208 service units.
- G2211 — Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 1,533 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 42 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 4,909 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Finasteride — 967 prescription fills, including refills.
- Tamsulosin Hcl — 922 prescription fills, including refills.
- Solifenacin Succinate — 291 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 42 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 90% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: 1,751. Middle half: 623 to 4,690.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 5,756 in 2020 to 13,227 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
12709 Toepperwein Rd Ste 206
Live Oak, TX 782333260
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 2 distinct group names: Urology Partners Of North Texas, Pllc; Urology San Antonio P A. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Texas Medical School At Houston
2011
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,737 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $598,066 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $475,099 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
11,459 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$3,648,057 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $896.45 across 31 records.
By nature of payment
- Food and Beverage: $896.45 across 31 records.
Reporting-company totals (3 largest of 13)
- Janssen Pharmaceuticals, Inc: $194.25 across 5 records.
- Dendreon Pharmaceuticals LLC: $164.96 across 5 records.
- Olympus America Inc.: $114.27 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
15 years (graduated 2011)
CMS Doctors and Clinicians data list 2011 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2011
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Cockerill has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Cockerill as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Live Oak and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 90% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: 1,751. Middle half: 623 to 4,690.
Too few clinicians listed under Urology in Live Oak have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: $130,907. Middle half: $56,287 to $242,595.
Too few clinicians listed under Urology in Live Oak have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Urology in Texas (2024, 608 clinicians with data). Median for this group: $98,400. Middle half: $41,252 to $185,944.
Too few clinicians listed under Urology in Live Oak have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Urology in Texas (2024, 667 clinicians with data). Median for this group: 1,254. Middle half: 393 to 2,342.
Too few clinicians listed under Urology in Live Oak have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Urology in Texas (2024, 667 clinicians with data). Median for this group: $146,128. Middle half: $29,835 to $354,962.
Too few clinicians listed under Urology in Live Oak have Medicare Part D data for 2024 to compare.
6 active clinicians are listed under Urology with a practice address in Live Oak, TX (961 in Texas).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 130% from 5,756 in 2020 to 13,227 in 2024.
- 2020: 5,756
- 2021: 7,072
- 2022: 7,841
- 2023: 8,181
- 2024: 13,227
-
Medicare-allowed amount
Medicare-allowed amount increased 107% from $288,977 in 2020 to $598,066 in 2024.
- 2020: $288,977
- 2021: $389,411
- 2022: $446,481
- 2023: $475,575
- 2024: $598,066
-
Paid by Medicare
Paid by Medicare increased 120% from $215,978 in 2020 to $475,099 in 2024.
- 2020: $215,978
- 2021: $299,485
- 2022: $352,645
- 2023: $365,734
- 2024: $475,099
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 86% from 2,645 in 2020 to 4,909 in 2024.
- 2020: 2,645
- 2021: 2,950
- 2022: 3,567
- 2023: 4,491
- 2024: 4,909
-
30-day fills
30-day fills increased 84% from 6,222 in 2020 to 11,459 in 2024.
- 2020: 6,222
- 2021: 7,110
- 2022: 8,319
- 2023: 10,436
- 2024: 11,459
-
Part D drug cost
Part D drug cost increased 347% from $816,874 in 2020 to $3,648,057 in 2024.
- 2020: $816,874
- 2021: $1,316,127
- 2022: $1,468,495
- 2023: $2,395,354
- 2024: $3,648,057
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $310.66 in 2021 to $896.45 in 2025.
- 2021: $310.66
- 2022: $142.00
- 2023: $238.78
- 2024: $581.98
- 2025: $896.45
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 31 records totaling $896.45.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $69.24 |
| Olympus America Inc. |
Food and Beverage
In-kind items and services
|
iTIND System | General | $57.08 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $44.40 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $34.92 |
| Blue Earth Diagnostics |
Food and Beverage
In-kind items and services
|
POSLUMA | General | $34.61 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $34.49 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $34.03 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $33.66 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $33.07 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $31.24 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $31.24 |
| Olympus America Inc. |
Food and Beverage
In-kind items and services
|
iTIND System | General | $31.14 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $30.32 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
LYNPARZA | General | $30.11 |
| Myriad Genetic Laboratories, Inc. |
Food and Beverage
In-kind items and services
|
PROLARIS | General | $27.91 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $27.24 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $26.58 |
| Olympus America Inc. |
Food and Beverage
In-kind items and services
|
iTIND System | General | $26.05 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $24.53 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $24.31 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $23.05 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $22.03 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $21.78 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
JELMYTO | General | $21.01 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $20.80 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J0897
Injection, denosumab, 1 mg
|
2,340 | 11 | $31.00 | $25.39 |
|
87798
Detection test by nucleic acid for organism, amplified probe technique
|
2,208 | 146 | $78.00 | $34.39 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
1,533 | 1,190 | $31.50 | $15.54 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
1,176 | 864 | $215.00 | $120.37 |
|
99490
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
|
886 | 166 | $102.00 | $59.28 |
|
81001
Manual urinalysis test with examination using microscope, automated
|
692 | 589 | $15.00 | $3.08 |
|
36415
Insertion of needle into vein for collection of blood sample
|
638 | 529 | $10.00 | $8.60 |
|
84153
Psa (prostate specific antigen) measurement, total
|
622 | 491 | $110.00 | $17.96 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
400 | 388 | $150.00 | $85.83 |
|
84403
Testosterone (hormone) level, total
|
280 | 189 | $150.00 | $25.20 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
247 | 229 | $95.00 | $10.29 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
227 | 227 | $313.00 | $157.04 |
|
87481
Detection test for candida species (yeast), amplified probe technique
|
184 | 146 | $78.00 | $34.39 |
|
87640
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
|
184 | 146 | $78.00 | $34.39 |
|
87653
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique
|
184 | 146 | $78.00 | $34.39 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
172 | 156 | $490.00 | $221.81 |
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
144 | 20 | $700.00 | $178.72 |
|
64566
Insertion of lower leg neurostimulator electrode
|
129 | 30 | $275.00 | $108.16 |
|
85014
Red blood cell concentration measurement
|
95 | 73 | $8.00 | $2.30 |
|
85018
Blood count, hemoglobin
|
95 | 73 | $8.00 | $2.30 |
|
80048
Blood test, basic group of blood chemicals (calcium, total)
|
83 | 66 | $45.00 | $8.29 |
|
96372
Injection of drug or substance under skin or into muscle
|
76 | 28 | $30.00 | $13.45 |
|
76770
Complete ultrasound scan behind abdominal cavity
|
66 | 61 | $345.00 | $97.10 |
|
85025
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
|
64 | 51 | $25.00 | $7.61 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
56 | 56 | $275.00 | $121.23 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Finasteride | Finasteride | 967 | 80,805 | $11,116.82 | 297 |
| Tamsulosin Hcl | Tamsulosin Hcl | 922 | 73,842 | $12,525.76 | 298 |
| Solifenacin Succinate | Solifenacin Succinate | 291 | 22,432 | $16,621.52 | 125 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 289 | 23,995 | $7,097.06 | 108 |
| Myrbetriq | Mirabegron | 231 | 15,076 | $223,775.83 | 78 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 227 | 19,870 | $4,443.53 | 69 |
| Orgovyx | Relugolix | 170 | 5,160 | $440,419.31 | 25 |
| Testosterone Cypionate | Testosterone Cypionate | 161 | 11,688 | $14,595.23 | 70 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 153 | 10,116 | $5,058.01 | 68 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 97 | 445 | $563.23 | 86 |
| Gemtesa | Vibegron | 83 | 4,837 | $75,723.37 | 20 |
| Erleada | Apalutamide | 82 | 2,460 | $1,063,788.96 | 12 |
| Sildenafil Citrate | Sildenafil Citrate | 73 | 3,017 | $806.88 | 20 |
| Oxybutynin Chloride | Oxybutynin Chloride | 72 | 5,098 | $2,053.73 | 34 |
| Nubeqa | Darolutamide | 67 | 2,010 | $845,192.02 | — |
| Cephalexin | Cephalexin | 64 | 3,495 | $663.57 | 36 |
| Methenamine Hippurate | Methenamine Hippurate | 64 | 4,360 | $3,747.57 | 20 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 64 | 955 | $674.08 | 50 |
| Dutasteride | Dutasteride | 60 | 5,315 | $1,793.25 | 18 |
| Xtandi | Enzalutamide | 59 | 1,770 | $756,749.17 | — |
| Estradiol | Estradiol | 56 | 3,635 | $3,765.91 | 36 |
| Terazosin Hcl | Terazosin Hcl | 54 | 4,860 | $917.85 | 17 |
| Abiraterone Acetate | Abiraterone Acetate | 53 | 1,590 | $100,491.84 | — |
| Prednisone | Prednisone | 49 | 1,621 | $282.85 | — |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 49 | 914 | $314.88 | 42 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20160629001490
TX
5395993331
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Urology Partners Of North Texas, Pllc
5001 S Cooper St, Arlington, TX 760175993
Urology Partners Of North Texas, Pllc
7718 Pasteur Ct, San Antonio, TX 782293473
Phone: 2104479060
Urology Partners Of North Texas, Pllc
3301 Matlock Rd, Arlington, TX 760152908
Phone: 6825096200
Urology San Antonio P A
12709 Toepperwein Rd, Live Oak, TX 782333260
Phone: 2105825505
Urology Partners Of North Texas, Pllc
7909 Fredericksburg Rd, San Antonio, TX 782293400
Phone: 2106144544
Urology Partners Of North Texas, Pllc
945 Hilltop Dr, Weatherford, TX 760865892
Phone: 8663678768
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner
Master of Science in Nursing, Advanced Practice Registered Nurse, Family Nurse Practitioner (Certified)
Nurse Practitioner - Family
Advanced Practice Registered Nurse, Family Nurse Practitioner (Certified)
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Nurse Practitioner - Acute Care
Urology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 12709 TOEPPERWEIN RD STE 206, LIVE OAK, TX 782333260 (Tel: 2105648000)
Registered at 7909 FREDERICKSBURG RD STE 110, SAN ANTONIO, TX 782293400 (Tel: 2106144544)
Urology (license number reported to NPPES: TX Q7028)
NPI status registered as active in NPPES database
Registered at 200 1ST ST SW, ROCHESTER, MN 559050001 (Tel: 5072842511)
Registered at 200 1ST ST SW, ROCHESTER, MN 559050001 (Tel: 5072842511)
Recorded as PATRICK COCKERILL, MD
Urology (license number reported to NPPES: MN 55250)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Urology Specialists in Live Oak
- Dr. David Talley, MD
- Dr. Vishal Patel, MD
- Dr. Katherine Cockerill, MD
- Dr. Lewis Russell, MD
- Dr. Terence Favazza, MD
Mailing Address
7909 Fredericksburg Rd Ste 110
San Antonio, TX 782293400
Phone: 2106144544